Healthcare | Advisory Council

Dr. Martin Rosenberg is currently the Chief Scientific Officer of the Promega Corporation, Madison, WI. He joined Promega after retiring in 2001 as Senior Vice President of Anti-Infectives Drug Discovery and Development at GlaxoSmithKline. He spent 20 years in the SmithKline R&D Organization and served as Senior Vice President in R&D since 1993. Dr. Rosenberg serves on the Board of Directors for the Promega Corporation, Madison, WI; the Medical College of Wisconsin Research Foundation, Milwaukee, WI; Nereus Pharmaceuticals, Inc., San Diego, CA; Anacor Pharmaceuticals, Palo Alto, CA; Cubist Pharmaceuticals, Lexington, MA; and Scarab Genomics, Madison, WI. He also serves as a member of the Advisory Council for the National Institutes of Allergy & Infectious Diseases at the National Institute of Health. He participates on a variety of academic and industry Scientific Advisory Boards and holds an adjunct Professorship at the University of Wisconsin, Department of Bacteriology, Madison, WI. Dr. Rosenberg is Editor-in-Chief of Current Opinions in Biotechnology, a Senior Editor of the Journal of Bacteriology and a member of several other journal Editorial Boards.

Before joining SmithKline Pharmaceutical R&D he spent 10 years at the National Institutes of Health and was a Section Chief in the National Cancer Institute. He has served as a member of the Executive Council for the National Institute of Allergy & Infectious Disease as well as a member of the Science Advisory Board of the FDA. He has been awarded the Arthur S. Fleming Award, the Panlabs Award in Microbiology, and the Distinguished Alumni Award from Purdue University. Dr. Rosenberg received his Ph.D. from Purdue and his postdoctoral training at Yale Medical School. He has published more than 200 papers and is the named inventor on more than 50 issued patents.